Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Retained Earnings (2020 - 2025)

Pulse Biosciences has reported Retained Earnings over the past 6 years, most recently at -$445.8 million for Q3 2025.

  • Quarterly results put Retained Earnings at -$445.8 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was -$445.8 million (changed N/A YoY), and the annual figure for FY2024 was -$390.5 million, changed.
  • Retained Earnings for Q3 2025 was -$445.8 million at Pulse Biosciences, down from -$426.5 million in the prior quarter.
  • Over the last five years, Retained Earnings for PLSE hit a ceiling of -$191.2 million in Q1 2021 and a floor of -$445.8 million in Q3 2025.
  • Median Retained Earnings over the past 5 years was -$300.0 million (2022), compared with a mean of -$307.2 million.
  • Biggest five-year swings in Retained Earnings: crashed 22080100.0% in 2021 and later fell 17.54% in 2023.
  • Pulse Biosciences' Retained Earnings stood at -$336.9 million in 2021, then grew by 15.26% to -$285.5 million in 2022, then fell by 10.13% to -$314.4 million in 2023, then decreased by 24.2% to -$390.5 million in 2024, then fell by 14.17% to -$445.8 million in 2025.
  • The last three reported values for Retained Earnings were -$445.8 million (Q3 2025), -$426.5 million (Q2 2025), and -$390.5 million (Q4 2024) per Business Quant data.